US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 50.620
  • +0.260+0.52%
Close Jul 19 16:00 ET
  • 51.200
  • +0.580+1.15%
Pre 07:17 ET
126.65BMarket Cap25.76P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanofi Earnings Date

Currency: EUR

Period

Q2 FY2024 Estimates

Jul 25, 2024

Revenue(YoY)

10.38B

+4.13%
EPS(YoY)

0.56

-3.73%
Analyst Rating

Buy

Jul 3, 2024

Sanofi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 25, 20242024/Q3-- / 12.951B--
Jul 25, 20242024/Q2-- / 10.377B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--
--2023/Q311.964B / 12.016B--
DatePeriodRevenue/EstimateEarnings Call
Oct 25, 20242024/Q3-- / 12.951B--
Jul 25, 20242024/Q2-- / 10.377B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--
--2023/Q311.964B / 12.016B--

Unlock Free Earnings Estimates

Sanofi Earnings Reports

  • Sanofi | 6-K: Colletion of Recent Announcements

    May 2 15:56 ET

  • Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance

    Apr 25 10:55 ET

  • Sanofi | 20-F: Registration statement / Annual report / Transition report

    Feb 23 11:20 ET

  • Sanofi | 6-K: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline

    Feb 1 09:46 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 3, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg